News | April 07, 2008

New Contrast Media Management Tool Features Touchscreen Operation

April 8, 2008 - Bayer HealthCare Pharmaceuticals Inc. collaborated with Mobile Aspects to create VistaTrak, a touchscreen contrast media management system that gives users a new management tool designed to help enhance patient care and safety, optimize inventory management and improve billing accuracy.

VistaTrak provides solutions for the use of contrast media and works by combining RFID technology of “tagged” bottles of contrast agent with a “smart” cabinet and an interface specifically created to capture, store and manage product utilization data while helping to reduce the risk of human error.

Available in two different sizes, the system facilitates patient safety by automatically screening data from a patient’s electronic medical record (EMR) for contraindications and prior adverse events. It also captures information stored on the tag, such as NDC number, expiration date and lot number, automatically, supporting compliance with accrediting organization requirements.

VistaTrak provides contrast-dosing information aimed at improving billing accuracy and helping address any existing issues with reimbursement or audits, and tracks inventory to enable departments to order and manage inventory more efficiently and reduce waste, according to the company.

The collaboration entailed Mobile Aspects’ iRIS platform for clinical environments that use contrast media. Bayer is reportedly the first company to offer a contrast media management system based on an RFID platform to automate manual processes and capture operational data that currently cannot be found in any one system.

For more information: www.pharma.bayer.com

Related Content

ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.
Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

Feature | Contrast Media Injectors | April 11, 2019 | By Jeff Zagoudis
One of the most controversial issues in radiology in recent years has been the use of...
Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...